U.S. markets open in 3 hours 36 minutes
  • S&P Futures

    3,279.75
    +4.75 (+0.15%)
     
  • Dow Futures

    27,034.00
    -21.00 (-0.08%)
     
  • Nasdaq Futures

    11,059.00
    +70.00 (+0.64%)
     
  • Russell 2000 Futures

    1,482.50
    -0.30 (-0.02%)
     
  • Crude Oil

    39.63
    +0.32 (+0.81%)
     
  • Gold

    1,909.60
    -1.00 (-0.05%)
     
  • Silver

    24.41
    +0.02 (+0.09%)
     
  • EUR/USD

    1.1744
    -0.0029 (-0.25%)
     
  • 10-Yr Bond

    0.6710
    0.0000 (0.00%)
     
  • Vix

    27.79
    +1.96 (+7.59%)
     
  • GBP/USD

    1.2786
    -0.0031 (-0.25%)
     
  • USD/JPY

    104.5540
    -0.1260 (-0.12%)
     
  • BTC-USD

    10,476.51
    +38.79 (+0.37%)
     
  • CMC Crypto 200

    213.09
    -22.49 (-9.55%)
     
  • FTSE 100

    5,822.28
    +17.99 (+0.31%)
     
  • Nikkei 225

    23,360.30
    +40.90 (+0.18%)
     

Insider Buying: Jack Schuler Just Spent US$8.0m On Aspira Women's Health Inc. (NASDAQ:AWH) Shares

Simply Wall St

Those following along with Aspira Women's Health Inc. (NASDAQ:AWH) will no doubt be intrigued by the recent purchase of shares by insider Jack Schuler, who spent a stonking US$8.0m on stock at an average price of US$3.50. While that only increased their holding size by 9.9%, it is still a big swing by our standards.

See our latest analysis for Aspira Women's Health

Aspira Women's Health Insider Transactions Over The Last Year

Notably, that recent purchase by Jack Schuler is the biggest insider purchase of Aspira Women's Health shares that we've seen in the last year. So it's clear an insider wanted to buy, at around the current price, which is US$3.53. Of course they may have changed their mind. But this suggests they are optimistic. We do always like to see insider buying, but it is worth noting if those purchases were made at well below today's share price, as the discount to value may have narrowed with the rising price. The good news for Aspira Women's Health share holders is that insiders were buying at near the current price.

Aspira Women's Health insiders may have bought shares in the last year, but they didn't sell any. The chart below shows insider transactions (by individuals) over the last year. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

NasdaqCM:AWH Insider Trading Volume July 8th 2020
NasdaqCM:AWH Insider Trading Volume July 8th 2020

There are always plenty of stocks that insiders are buying. So if that suits your style you could check each stock one by one or you could take a look at this free list of companies. (Hint: insiders have been buying them).

Does Aspira Women's Health Boast High Insider Ownership?

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. I reckon it's a good sign if insiders own a significant number of shares in the company. Aspira Women's Health insiders own 39% of the company, currently worth about US$143m based on the recent share price. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.

So What Do The Aspira Women's Health Insider Transactions Indicate?

The recent insider purchase is heartening. And an analysis of the transactions over the last year also gives us confidence. But we don't feel the same about the fact the company is making losses. When combined with notable insider ownership, these factors suggest Aspira Women's Health insiders are well aligned, and quite possibly think the share price is too low. One for the watchlist, at least! So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. To that end, you should learn about the 4 warning signs we've spotted with Aspira Women's Health (including 1 which can't be ignored).

Of course Aspira Women's Health may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.